Skip to main content

Corporate insider profile

Dennis Podlesak Insider Trades

Dennis Podlesak has reported no open-market purchases on SEC Form 4 and is a net seller of $113,716 across 1 company. The most recent open-market transaction was reported on Oct 29, 2026. Source: SEC Form 4 filings.

Latest reported as Director of Syndax Pharmaceuticals Inc (SNDX).

SEC-reported filing activity is provided for research purposes and is not investment advice.

Purchase filings
0
Reported companies
1
Net open-market value
-$113,716.00
Latest transaction
Oct 29, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 29, 2026Syndax Pharmaceuticals Inc (SNDX)DirectorSale8,000$14.21$113,716

Common questions

Dennis Podlesak insider trading FAQ

Is Dennis Podlesak buying or selling stock?
Across all SEC Form 4 open-market filings on record, Dennis Podlesak is a net seller of $113,716, with no open-market purchases reported. The latest transaction was reported on Oct 29, 2026.
Which companies does Dennis Podlesak report insider trades for?
Dennis Podlesak has reported open-market trades in Syndax Pharmaceuticals Inc (SNDX). The latest SEC-reported relationship is Director of Syndax Pharmaceuticals Inc (SNDX).
Where does Dennis Podlesak's insider trading data come from?
Watch Insiders reads the SEC Form 4 filings submitted to EDGAR under reporting owner CIK 1314595, and refreshes this page daily.